NCT04019080Unknown不适用
Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden
Karolinska University Hospital1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2019年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 400
- 试验地点
- 1
- 主要终点
- Anti-fibrotic drugs among the patients recorded in the Swedish IPF-registry
研究概览
简要总结
The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All subjects included in the Swedish IPF-registry
排除标准
- 未提供
结局指标
主要结局
Anti-fibrotic drugs among the patients recorded in the Swedish IPF-registry
时间窗: 2014-2020
The use of anti-fibrostic drugs
次要结局
未报告次要终点
研究者
Magnus Skold
Professor, Senior consultant
Karolinska University Hospital
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)Neovascular Age-related Macular DegenerationDiabetic Macular EdemaNCT06680817Hoffmann-La Roche850
已完成
不适用
Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*)Cystic FibrosisNCT03475381Assistance Publique - Hôpitaux de Paris852
已完成
不适用
Real-life-persistence to Antifibrotic TreatmentsIdiopathic Pulmonary FibrosisNCT06485635Boehringer Ingelheim10,646
招募中
不适用
An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth TechnologyPulmonary FibrosisNCT04304898Erasmus Medical Center700
进行中（未招募）
2 期
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DMFibrosis, LiverType 2 Diabetes Mellitus in ObeseNon-Alcoholic Fatty Liver DiseaseNCT06005012University of California, San Diego120